Baxter - 44 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits and dividends. The latest closing stock price for Baxter as of July 02, 2025 is 31.13.
- The all-time high Baxter stock closing price was 84.47 on April 20, 2020.
- The Baxter 52-week high stock price is 40.49, which is 30.1% above the current share price.
- The Baxter 52-week low stock price is 26.25, which is 15.7% below the current share price.
- The average Baxter stock price for the last 52 weeks is 33.38.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 31.2951 | 28.9570 | 36.3675 | 27.6461 | 31.1300 | 7.87% |
| 2024 | 36.0112 | 37.3689 | 42.3972 | 28.3336 | 28.8581 | -22.40% |
| 2023 | 38.7614 | 47.6825 | 49.1119 | 30.2581 | 37.1862 | -21.91% |
| 2022 | 62.3073 | 79.7576 | 82.1264 | 46.4400 | 47.6171 | -39.58% |
| 2021 | 73.5244 | 72.5392 | 80.0514 | 67.2341 | 78.8120 | 8.48% |
| 2020 | 75.6917 | 76.8578 | 84.4733 | 64.2209 | 72.6479 | -2.93% |
| 2019 | 70.9595 | 57.8302 | 80.1429 | 57.1040 | 74.8439 | 28.40% |
| 2018 | 61.5457 | 58.8721 | 68.7079 | 54.3658 | 58.2908 | 2.89% |
| 2017 | 50.5963 | 38.5501 | 57.7483 | 38.5501 | 56.6546 | 47.30% |
| 2016 | 37.8551 | 31.8723 | 42.5206 | 29.8058 | 38.4633 | 17.58% |
| 2015 | 31.9300 | 33.9366 | 35.9046 | 27.5868 | 32.7126 | -3.58% |
| 2014 | 33.4565 | 32.0293 | 35.6447 | 30.7794 | 33.9273 | 5.38% |
| 2013 | 32.1053 | 31.3164 | 34.4550 | 29.5759 | 32.1960 | 4.34% |
| 2012 | 26.8620 | 23.3959 | 31.8534 | 22.6969 | 30.8581 | 34.72% |
| 2011 | 25.1603 | 23.4004 | 28.8907 | 22.0580 | 22.9052 | -2.25% |
| 2010 | 23.0997 | 26.9833 | 28.5665 | 18.7342 | 23.4328 | -13.74% |
| 2009 | 25.0074 | 25.4974 | 28.0064 | 21.4839 | 27.1639 | 9.50% |
| 2008 | 28.4440 | 26.7518 | 32.9364 | 22.4514 | 24.8077 | -7.68% |
| 2007 | 25.3586 | 21.5255 | 28.2795 | 21.4468 | 26.8722 | 25.13% |
| 2006 | 18.9496 | 17.7574 | 21.8542 | 16.4103 | 21.4746 | 23.21% |
| 2005 | 17.2522 | 16.0261 | 18.9563 | 15.4474 | 17.4287 | 9.00% |
| 2004 | 14.5741 | 13.9661 | 16.0122 | 13.3134 | 15.9890 | 13.17% |
| 2003 | 12.3035 | 13.2810 | 14.4429 | 8.5917 | 14.1281 | 9.00% |
| 2002 | 19.9720 | 24.5807 | 27.5896 | 11.2118 | 12.9616 | -47.79% |
| 2001 | 22.4176 | 20.7443 | 25.6917 | 18.8637 | 24.8260 | 21.45% |
| 2000 | 16.5763 | 14.2056 | 20.5707 | 11.9923 | 20.4405 | 40.60% |
| 1999 | 15.1480 | 14.6252 | 17.5762 | 13.5836 | 14.5383 | -2.33% |
| 1998 | 13.2598 | 11.6017 | 15.2761 | 11.2690 | 14.8855 | 27.51% |
| 1997 | 11.6343 | 9.4029 | 13.9019 | 9.4029 | 11.6741 | 23.02% |
| 1996 | 10.1454 | 9.6344 | 11.0809 | 9.2583 | 9.4898 | -2.09% |
| 1995 | 8.2352 | 6.5097 | 9.8369 | 6.2782 | 9.6922 | 48.23% |
| 1994 | 5.9141 | 5.6417 | 6.6254 | 5.0920 | 6.5387 | 15.90% |
| 1993 | 6.2402 | 7.3777 | 7.3777 | 4.6870 | 5.6417 | -24.71% |
| 1992 | 7.6284 | 8.2510 | 8.4349 | 6.4641 | 7.4934 | -10.88% |
| 1991 | 7.1113 | 5.7546 | 8.4875 | 5.3868 | 8.4086 | 43.50% |
| 1990 | 5.1768 | 5.3605 | 6.0963 | 4.3357 | 5.8598 | 11.50% |
| 1989 | 4.5191 | 3.7050 | 5.3868 | 3.7050 | 5.2554 | 41.85% |
| 1988 | 4.3545 | 4.9138 | 5.4393 | 3.4685 | 3.7050 | -22.53% |
| 1987 | 5.0936 | 3.9941 | 6.1225 | 3.8627 | 4.7824 | 18.18% |
| 1986 | 3.8156 | 3.2583 | 4.4408 | 3.2058 | 4.0467 | 22.22% |
| 1985 | 3.0706 | 2.7591 | 3.4948 | 2.6277 | 3.3109 | 20.00% |
| 1984 | 3.4263 | 4.8875 | 5.1503 | 2.5226 | 2.7591 | -43.55% |
| 1983 | 5.6239 | 4.8744 | 6.5824 | 4.4933 | 4.8875 | -3.88% |
| 1982 | 4.0776 | 3.6000 | 5.3080 | 3.2846 | 5.0846 | 44.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.026B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.070B | 28.51 |
| Boston Scientific (BSX) | United States | $155.016B | 38.81 |
| Stryker (SYK) | United States | $151.431B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $128.578B | 0.00 |
| Medtronic (MDT) | Ireland | $113.826B | 16.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.396B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.515B | 26.54 |
| ResMed (RMD) | United States | $37.575B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.776B | 16.51 |
| Agilent Technologies (A) | United States | $34.216B | 22.31 |
| Terumo (TRUMY) | Japan | $26.620B | 34.58 |
| Koninklijke Philips (PHG) | Netherlands | $23.303B | 16.35 |
| Insulet (PODD) | United States | $21.112B | 82.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.610B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.402B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.748B | 23.48 |
| Lantheus Holdings (LNTH) | United States | $5.495B | 13.86 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 17.73 |
| Perrigo (PRGO) | Ireland | $3.771B | 9.56 |
| Haemonetics (HAE) | United States | $3.667B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.393B | 28.20 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| QuidelOrtho (QDEL) | United States | $2.015B | 13.86 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.594B | 0.00 |
| Acuren (TIC) | United States | $1.327B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.269B | 12.88 |
| Green Thumb Industries (GTBIF) | United States | $1.158B | 26.05 |
| Neogen (NEOG) | United States | $1.103B | 14.11 |
| Phibro Animal Health (PAHC) | United States | $1.079B | 13.79 |
| BioLife Solutions (BLFS) | United States | $1.029B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 9.45 |
| Kestra Medical Technologies (KMTS) | United States | $0.813B | 0.00 |
| Owens & Minor (OMI) | United States | $0.728B | 6.04 |
| CeriBell (CBLL) | United States | $0.671B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.443B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Surmodics (SRDX) | United States | $0.419B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.353B | 12.98 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.33 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| ZimVie (ZIMV) | United States | $0.274B | 12.46 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 64.88 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 71.67 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Omeros (OMER) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.50 |
| TerrAscend (TSNDF) | Canada | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.75 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |